655255-09-7 Usage
Uses
Used in Oncology:
4-CHLOROFURO[3,2-D]PYRIMIDINE is used as an antineoplastic agent for its potential to treat various cancers. It is particularly effective against breast and lung cancer due to its ability to inhibit the growth of cancer cells by blocking the production of DNA and RNA.
Used in Cancer Research:
In the field of cancer research, 4-CHLOROFURO[3,2-D]PYRIMIDINE is used as a cytotoxic compound to study its effects on cancer cells and to explore its potential as a targeted cancer therapy. Its unique structure and mechanism of action provide valuable insights into the development of new cancer treatments.
Used in Drug Development:
4-CHLOROFURO[3,2-D]PYRIMIDINE is utilized in drug development as a potential candidate for the creation of new antineoplastic drugs. Its effectiveness in inhibiting cancer cell growth and its unique mechanism of action make it a promising compound for further research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 655255-09-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,5,2,5 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 655255-09:
(8*6)+(7*5)+(6*5)+(5*2)+(4*5)+(3*5)+(2*0)+(1*9)=167
167 % 10 = 7
So 655255-09-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClN2O/c7-6-5-4(1-2-10-5)8-3-9-6/h1-3H
655255-09-7Relevant academic research and scientific papers
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists
Hu, Yun-Jin,St.-Onge, Miguel,Laliberté, Sébastien,Vallée, Frédéric,Jin, Shujuan,Bedard, Leanne,Labrecque, Jean,Albert, Jeffrey S.
supporting information, p. 3199 - 3203 (2015/02/19)
A series of TRPA1 antagonists is described having a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine or a 1-aryloxyisoquinoline scaffold. These compounds have high ligand efficiency and favorable physical properties and may thus serve as scaffolds for further optimization.
THERAPEUTIC AGENTS
-
Page/Page column 41, (2010/04/03)
The invention provides a compound of formula (I): wherein R1, and W have any of the values defined in the application; or a salt thereof. The compounds and salts thereof have beneficial therapeutic properties (e.g. immunosuppressant properties).
